A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Weight loss drugs have become popular due to social media and celebrities using them to shed excess pounds quickly. Although ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently ...

Congress is pushing companies like Ozempic and Wegovy, which make weight loss drugs that have changed the lives of millions ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...